Healthcare Finance News March 1, 2024
Traditional monitoring methods can incur unnecessary costs and potentially extra steps, Signify says.
Signify Health, a subsidiary of CVS Health, will add a heart arrhythmia test to its Diagnostic and Preventive Services offering. The move is intended to broaden Signify’s range of in-home services designed to support earlier detection, diagnosis and management of various medical conditions.
The prevalence of heart arrhythmias, or irregular heartbeat, is expected to grow because of the aging U.S. population. Atrial Fibrillation is the most common arrhythmia, with an estimated one-third of adults being asymptomatic and between 1.26 and 1.52 million cases being undiagnosed, a pair of studies show.
People with undiagnosed heart arrhythmias struggle with symptoms such as chest pain, rapid and irregular heartbeat,...